Potential Route for Zika from Mother to Fetus

Placental macrophages called Hofbauer cells are particularly vulnerable to infection by the virus, a study shows.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Zika virus particles (blue) WIKIMEDIA, CDC, CYNTHIA GOLDSMITHThe Zika virus may pass from a pregnant woman to her developing fetus via placental immune cells known as Hofbauer cells, according to a study published last week (May 27) in Cell Host & Microbe. The findings highlight a possible transmission route for the virus, which has been linked to microcephaly and other birth defects in more than a quarter of babies born to infected mothers.

“Our study indicates that this cell type may be a target for Zika virus in the placenta,” study coauthor Rana Chakraborty of Emory University School of Medicine said in a statement. “Replication in these cells may allow the virus to cross the placental barrier and enter the fetal circulation.”

Until now, the path of the virus from mother to fetus has remained elusive. In fact, some cells in the outermost cell layer of the placenta have been shown to be fairly resistant to Zika infection and may even act as a barrier to transmission.

In the present study, the team used human placentae from five donors to identify Hofbauer cells as particularly vulnerable to Zika infection. Cells called cytotrophoblasts present in the middle layer of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies